Melanoma: Vaccine Shows Promise

A peptide vaccine was tested in 26 patients with stages 3 and 4 melanoma Partial responses were noted. [P] Reference: Nov 1,2003 Issue of the journal of clinical Oncology. [P] Contact: Dr. Slingluff University of Virginia.

Webmaster

February 02, 2004